approval
saveJASCAYD (NERANDOMILAST) — FDA approval
community read0 votes
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalCYLTEZO: CYLTEZO (ADALIMUMAB-ADBM) — FDA approvalOct 16, 2025
- approvalspesolimab: SPEVIGO (SPESOLIMAB-SBZO) — FDA approvalOct 21, 2025
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approval(empagliflozin + linagliptin): GLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approvalSYNJARDY: SYNJARDY (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
- approval(empagliflozin + linagliptin + metformin hydrochloride) ER: TRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025
comments(0)
5-min edit window · permanent after that